mProX™ Human MAS1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
There are currently no Customer reviews or questions for mProX™ Human MAS1 Stable Cell Line (S01YF-1023-PY248). Click the button above to contact us or submit your feedback about this product.
Taylor Davis (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Taylor Garcia (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Published Data
Fig.1 The growth of MCF-7 and MDA-MB-468 cells was examined in relation to the knockdown of MAS1 and subsequent treatment with TMX and/or A1-7, with a focus on the effects induced by these interventions.
TMX treatment resulted in an increase in MAS1 expression in MCF-7 cells, while no such effect was observed in MDA-MB-468 cells. Inhibition of growth was observed in MCF-7 cells when treated with TMX alone or A1-7 alone. Furthermore, when TMX and A1-7 were administered concurrently, synergic effects were witnessed in MCF-7 cells. In contrast, A1-7 treatment inhibited growth in MDA-MB-468 cells, but TMX did not exert a similar influence. The growth-inhibitory effects of A1-7 were nullified by MAS1 knockdown. Consequently, A1-7 treatment exhibited effectiveness in both non-TNBC and TNBC cells; nonetheless, the potential for synergistic effects with anti-estrogen treatment could be anticipated in non-TNBC cells.
Ref: Luo, Yi, et al. "Expression of MAS 1 in breast cancer." Cancer Science 106.9 (2015): 1240-1248.
Pubmed: 26080617
DOI: 10.1111/cas.12719
Research Highlights
Wang, Zheng. et al. "Origins of lineage-specific elements via gene duplication, relocation, and regional rearrangement in Neurospora crassa." Molecular ecology, 2023.
Evolutionary biologists have long been intrigued by the emergence of new genes, which elude traditional evolutionary modeling due to their novelty. To delve into their origins, researchers focus on well-sampled clades like Neurospora, a genus devoid of recent gene duplications. Through gene synteny analysis, they found that 78% of Neurospora's lineage-specific genes (LSGs) cluster near telomeres, often with non-coding DNA and duplicated genes. Some LSGs appear to result from regional rearrangements or gene rebirth. Transcriptomics data from 68 experiments revealed that LSGs play peripheral roles across various functions. The ancestral roots of LSG mas-1, linked to cell-wall integrity and antifungal toxin sensitivity, trace back to an ancient lysophospholipase precursor in Sordariomycetes. These findings shed light on a "rummage region" in the N. crassa genome, enabling the formation of new genes and functions through duplication, relocation, and rapid mutation facilitated by sequence repeats and unconstrained non-coding sequences.
Wang, Zheng. et al. "Origins of lineage-specific elements via gene duplication, relocation, and regional rearrangement in Neurospora crassa." Molecular ecology, 2023.
Pubmed:
37843462
DOI:
10.1111/mec.17168
M Tayler, Hannah. et al. "Altered gene expression within the renin-angiotensin system in normal ageing and dementia." The journals of gerontology. Series A, Biological sciences and medical sciences, 2023.
The renin-angiotensin system (RAS) has been found to be altered in Alzheimer's disease (AD). The aim of this study was to examine the hypothesis that an imbalance in brain RAS associated with age could be a trigger for RAS changes observed in AD. RAS gene expression was assessed in the frontal cortex of two cohorts: a group of individuals experiencing normal aging (n=99; age range 19-96 years) and a case-control cohort (n=209) with various forms of dementia, including AD (n=66), mixed dementia (VaD + AD) (n=50), pure vascular dementia (VaD) (n=42), and age-matched healthy controls (n=51). Within the AD, mixed dementia, and age-matched control groups, participants were further categorized based on the Braak tangle stage (BS): BS0-II (n=48), BSIII-IV (n=44), and BSV-VI (n=85). The expression of genes related to classical RAS signaling (ACE1, AGTR1, and AGTR2) and protective downstream regulatory RAS signaling (ACE2, MAS1, and LNPEP) was measured. Gene expression data was adjusted for reference genes (RPL13 and UBE2D2) and cell-specific calibrator genes (NEUN, GFAP, and PECAM). The results showed elevated expression of ACE1 and AGTR1 in normal aging, but no changes in markers of protective RAS signaling, such as ACE2, MAS1, and LNPEP. In AD and mixed dementia, AGTR1 and AGTR2 expression were elevated in BSIII-IV and BSV-VI, respectively. MAS1 expression was reduced in BSV-VI and inversely correlated with parenchymal Aβ and tau load. LNPEP expression was specifically elevated in VaD. These findings provide new insights into RAS signaling in both normal aging and dementia.
M Tayler, Hannah. et al. "Altered gene expression within the renin-angiotensin system in normal ageing and dementia." The journals of gerontology. Series A, Biological sciences and medical sciences, 2023.
Pubmed:
37813091
DOI:
10.1093/gerona/glad241